Table 1.
Multiple sclerosis patients | Healthy subjects | |
---|---|---|
Sex, n (male/female) | 150 (58/92) | 100 (46/54) |
Age (years), mean ± SD | 45 ± 15 | 38 ± 13 |
EDSS score, median (range) | 3.63 (0–8) | – |
Disease course (RR/PMS) | 92/58 | – |
Disease-modifying therapy (n) | Untreated (15) Interferon-beta (8) Glatiramer acetate (7) Dimethyl fumarate (26) Fingolimod (16) Natalizumab (3) Rituximab (5) Ocrelizumab (60) Siponimod (2) Teriflunomide (8) |